EP1670514 - Bibliographic data

ANTITUMOR AGENT COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A TOPOISOMERASE II INHIBITOR

Last update 10/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

ASTELLAS PHARMA INC.

3-11, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411
Japon
(72) Inventors

NAOE, Yoshinori

4034-18-103, Izumi-cho, Izumi-ku
Yokohama-shi, Kanagawa 245-0016
Japon

SASAKAWA, Yuka

c/o Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411
Japon
(74) Agent

Mail recipient

GILLE HRABAL

Patentanwälte Brucknerstrasse 20
40593
Düsserdolf
Allemagne

(21) Request number EP04773539.4
(22) Request date 24/09/2004

(11) Publication number EP1670514
Publication date 23/06/2010

(54) Title of the invention ANTITUMOR AGENT COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A TOPOISOMERASE II INHIBITOR
(51) International classification A61P 35/00
International classification (before reform) None

Claimed priority

(31) Number: 2003334340
(32) Date: 25/09/2003
(33) Country: JP


(31) Number: 2003344315
(32) Date: 02/10/2003
(33) Country: JP

Initial application None
Divisional application EP10163527.4 /EP2263694 None

Expected annuity Annuity: 7 - Amount: 90 € - Due date 30/09/2010
Surtax: 7 - Amount: 18 € - Due date 31/03/2011
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2010/2, of 30/06/2010

History

Publication de la délivrance du brevet européen - Legal date 23/06/2010


Déchéance du brevet d'invention après période de grâce - Legal date 30/09/2010


Entrée en période de grâce du brevet d'invention - Legal date 30/09/2010